Jeff Myers has nearly 15 years of experience in biotech. He has served in a number of leadership roles in drug and device development, with both Portola and SteadyMed eventually being acquired. Jeff has held critical positions in clinical and business development, regulatory and other key functions.
Prior to his career in industry, Jeff was a pediatric cardiac and transplant surgeon, with his last appointment being at the Massachusetts General Hospital and Harvard University. During that time, he also ran a research lab studying the mechanism of pulmonary hypertension in newborns.
- M.D., with Honors, University of Oklahoma Medical School
- Ph.D., with Distinction, Georgetown University